Manhattan, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)PANCREATIC CANCER NORTH AMERICA INC, founded in 2020, is a small nonprofit in the Health Care sector that reported $129K in total revenue in fiscal year 2024. Revenue decreased 9% compared to the prior year. Expenses of $167K exceeded revenue, resulting in a 30% operating deficit.
Pancreatic Cancer North America aims to fundamentally change the experience of pancreatic cancer for patients and their families, and redefine it from a death sentence to a survivable cancer. We focus on accelerating research, expanding our programs and supports while increasing awareness and visibility of pancreatic cancer.
Pancreatic Cancer North America provided a research grant totaling $60,000 to the Dana-Farber Cancer Institute in support of the pilot study of psilocybin assisted therapy for opioid refractory...
Pancreatic Cancer North America provided a research grant totaling $60,000 to the Dana-Farber Cancer Institute in support of the pilot study of psilocybin assisted therapy for opioid refractory cancer pain in patients with advanced cancer, and to advance the search for cures and prevention for all cancers.
Pancreatic Cancer North America provided a grant totaling $19,375 to Cancer Care in support of the mental health and supportive counseling for people affected by cancer.
Pancreatic Cancer North America continued its commitment to raising awareness of pancreatic cancer and advocating for greater supports, by working with healthcare professionals, allied organizations...
Pancreatic Cancer North America continued its commitment to raising awareness of pancreatic cancer and advocating for greater supports, by working with healthcare professionals, allied organizations and in particular during World Pancreatic Cancer Day.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $128,661 | $140,713 | -0.1% |
| Expenses | $167,270 | $150,582 | +0.1% |
| Net Income | $-38,609 | $-9,869 | +2.9% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Jonathan Paul | Board Chair | 1 |
Director
|
$0 | $0 | $0 |
| Michael Gilbert | Board Vice Chair and Treasurer | 1 |
Director
|
$0 | $0 | $0 |
| Lauren Israel | Board Director | 1 |
Director
|
$0 | $0 | $0 |
| Russell Browne | Board Director | 1 |
Director
|
$0 | $0 | $0 |
| Christopher Andrews | Board Director | 1 |
Director
|
$0 | $0 | $0 |
| Elfreda Lau | Board Director | 1 |
Director
|
$0 | $0 | $0 |
| Linda Shick | Board Director | 1 |
Director
|
$0 | $0 | $0 |
| Richard Weldon | Board Director | 1 |
Director
|
$0 | $0 | $0 |
| Michelle Capobianco | President & CEO & Secretary | 25 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $128,661 | $167,270 | $69,323 | $-38,609 |
| 2023 | $140,713 | $150,582 | $96,001 | $-9,869 |
| 2022 | $223,232 | $255,696 | $116,634 | $-32,464 |
| 2021 | $254,134 | $116,128 | $138,334 | $138,006 |
Compare PANCREATIC CANCER NORTH AMERICA INC with other nonprofits in New York and across the country.